Novartis Home

Novartis scientist working in a lab

At Novartis, we are reimagining medicine

Behind the research driving our data

Novartis data at 2019 ASH and SABCS underscore our evolving R&D approach in innovative platforms to reimagine medicine and help improve patient outcomes.

Learn More

A decades-long journey in blood cancer research

Novartis immunologist describes the excitement of discovering a promising new immuno-oncology target in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome.

Learn More

Accelerating our digital transformation with Amazon Web Services (AWS)

We are collaborating with AWS to build an enterprise-wide data and analytics platform to help transform business operations, starting with the way medicines are manufactured and delivered.

Learn More

New cell and gene facility inaugurated in Switzerland

Novartis opens facility for innovative cell and gene therapies at our Stein manufacturing site in the canton of Aargau.

Learn More